DEVELOPMENT OF BISPECIFIC, T-CELL ENGAGING, CYTOKINE-LOADED NANOPARTICLES (BITEOKINES) FOR THE TREATMENT OF CHILDHOOD CANCERS

Emory University, Atlanta GA

Investigators